SEC Comment Letter for Cabaletta Bio, Inc. (CABA) (CIK 0001759138) (CABA) — Nov 16, 2020
Cabaletta Bio, Inc. (CABA) (CIK 0001759138)
Date: Nov. 16, 2020 · CIK: 0001759138 · Accession: 0000000000-20-010939
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-250006
Letter
United States securities and exchange commission logo November 16, 2020 Steven Nichtberger President and Chief Executive Officer Cabaletta Bio, Inc. 2929 Arch Street, Suite 600 Philadelphia, Pennsylvania 19104 Re:Cabaletta Bio, Inc. Registration Statement on Form S-3 Filed November 10, 2020 File No. 333-250006 Dear Mr. Nichtberger: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
November 16, 2020
Steven Nichtberger
President and Chief Executive Officer
Cabaletta Bio, Inc.
2929 Arch Street, Suite 600
Philadelphia, Pennsylvania 19104
Re:Cabaletta Bio, Inc.
Registration Statement on Form S-3
Filed November 10, 2020
File No. 333-250006
Dear Mr. Nichtberger:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences